SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · The court granted in part the government's motion to compel in a False…

REGENERON PHARMACEUTICALS, INC. · COURT-RULING filed Nov 1, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

COURT-RULING filed Nov 1, 2026 at 19:00 ET

The court granted in part the government's motion to compel in a False Claims Act case against Regeneron, finding that Regeneron impliedly waived attorney-client privilege over documents related to outside counsel's 2017 comment that classifying credit card fees as BFSFs was 'very questionable.' The ruling is interlocutory and procedural, it compels document production but does not resolve liability or damages.

  • Court found Regeneron impliedly waived attorney-client privilege over communications related to outside counsel Stephanie Trunk's 2017 comment that classifying credit card fees as BFSFs was 'very questionable'.
  • Regeneron must produce documents and communications related to Trunk's comment forthwith.
  • No damages were awarded; no injunction was issued; the case remains pending.
  • The ruling is interlocutory and does not determine liability or the merits of the False Claims Act allegations.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access